Cardiology in the young
-
Cardiology in the young · Dec 2009
Multicenter StudyA multicentric study of disease-related stress, and perceived vulnerability, in parents of children with congenital cardiac disease.
Parents of children with congenitally malformed hearts can suffer from stress as a result of the medical condition of their child. In this cross-sectional study, we aimed to describe levels of parental stress, and perceived vulnerability, in parents of children who underwent major cardiac surgery, by using both generic and disease-related measures for assessment. We included parents of children who underwent open-heart surgery over the period 2002 through 2007 in the Center for congenital Anomalies Heart Amsterdam/Leiden, abbreviated to provide the acronym CAHAL. ⋯ Risk factors for increased anxiety and perceived vulnerability were found in the number of surgical procedures, the time past since the last procedure, and ethnicity. Severity of the lesion did not influence parental levels of stress, but parents of children with hypoplastic left heart syndrome did report higher levels of stress than other parents. Psychosocial screening of parents of children with congenitally malformed hearts is important in order to provide appropriate counselling to those parents most in need.
-
Cardiology in the young · Dec 2009
Case ReportsStenosis of the main stem of the left coronary artery in a teenager with Takayasu's arteritis.
Coronary arterial involvement is rare in Takayasu's arteritis. We describe successful coronary arterial bypass grafting in a 15 year teenager with Takayasu's arteritis and unstable angina because of stenosis of the main stem of the left coronary artery.
-
Cardiology in the young · Nov 2009
Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges.
Heart failure is a leading cause of death worldwide. Current therapies only delay progression of the cardiac disease or replace the diseased heart with cardiac transplantation. Stem cells represent a recently discovered novel approach to the treatment of cardiac failure that may facilitate the replacement of diseased cardiac tissue and subsequently lead to improved cardiac function and cardiac regeneration. ⋯ As of now, bone marrow derived stem cells have not been proven to differentiate reproducibly and reliably into cardiomyocytes. Skeletal myoblasts have created in vivo myotubes but have not electrically integrated with the myocardium. Cardiac stem cells and cardiac progenitor cells represent one of the most promising types of cellular therapy for children with cardiac failure.